Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatic inflammatory responses in liver fibrosis
Linda Hammerich, Frank Tacke
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 10, pp. 633-646
Closed Access | Times Cited: 291

Showing 1-25 of 291 citing articles:

Metabolic reprogramming in liver fibrosis
Paul Horn, Frank Tacke
Cell Metabolism (2024) Vol. 36, Iss. 7, pp. 1439-1455
Open Access | Times Cited: 51
Protein neddylation and its role in health and diseases
Shizhen Zhang, Qing Yu, Zhijian Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 34
NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options
Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 366-366
Open Access | Times Cited: 20
Esculin inhibits hepatic stellate cell activation and CCl4-induced liver fibrosis by activating the Nrf2/GPX4 signaling pathway
Shuoxi Xu, Yonger Chen, Jindian Miao, et al.
Phytomedicine (2024) Vol. 128, pp. 155465-155465
Closed Access | Times Cited: 19
The m6A reader IGF2BP2 regulates glycolytic metabolism and mediates histone lactylation to enhance hepatic stellate cell activation and liver fibrosis
Yongqiang Zhou, Jiexi Yan, He Huang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 17
Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation
Cédric Peleman, Sven Francque, Tom Vanden Berghe
EBioMedicine (2024) Vol. 102, pp. 105088-105088
Open Access | Times Cited: 15
Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells
Hikmet Akkız, Robert K. Gieseler, Ali Canbay
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7873-7873
Open Access | Times Cited: 15
A novel deacetylase inhibitor KLX suppresses liver fibrosis by deacetylating PPARγ through promoting ubiquitination-mediated HDAC1 degradation
Feng Zhang, Jinglun Song, Han Wu, et al.
Science China Life Sciences (2025)
Closed Access | Times Cited: 2
Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis
Jiaorong Qu, Le Wang, Yufei Li, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 3, pp. 303-325
Open Access | Times Cited: 11
Mesenchymal stem cells alleviate mouse liver fibrosis by inhibiting pathogenic function of intrahepatic B cells
Xudong Feng, Bing Feng, Jiahang Zhou, et al.
Hepatology (2024)
Open Access | Times Cited: 10
Liver Fibrosis Amelioration by Macrophage-Biomimetic Polydopamine Nanoparticles via Synergistically Alleviating Inflammation and Scavenging ROS
Zhe Ma, Xiaojie Tian, Shijiang Yu, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 6, pp. 3040-3052
Closed Access | Times Cited: 10
Macrophage and fibroblast trajectory inference and crosstalk analysis during myocardial infarction using integrated single-cell transcriptomic datasets
Da Ke, Mingzhen Cao, Jian Ni, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Inflammation in Alcohol-Associated Hepatitis: Pathogenesis and Therapeutic Targets
Dechun Feng, Seonghwan Hwang, Adrien Guillot, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 18, Iss. 3, pp. 101352-101352
Open Access | Times Cited: 9
Meta‐analysis: Efficacy and safety of fibroblast growth factor 21 analogues for the treatment of non‐alcoholic steatohepatitis and non‐alcoholic steatohepatitis‐related fibrosis
Rutao Lin, Jianghua Zhou, Qinmei Sun, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 7, pp. 802-811
Closed Access | Times Cited: 8
Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions
Mengyao Yan, Cui Yi-min, Qian Xiang
Theranostics (2025) Vol. 15, Iss. 5, pp. 1715-1740
Open Access | Times Cited: 1
Long-term risk of chronic liver disease in patients with celiac disease: a nationwide population-based, sibling-controlled cohort study
Jialu Yao, Jiangwei Sun, Fahim Ebrahimi, et al.
The Lancet Regional Health - Europe (2025) Vol. 50, pp. 101201-101201
Open Access | Times Cited: 1
Noncoding RNAs in sepsis-associated acute liver injury: Roles, mechanisms, and therapeutic applications
Jialian Wang, Xingyu Tao, Zhengyang Liu, et al.
Pharmacological Research (2025) Vol. 212, pp. 107596-107596
Open Access | Times Cited: 1
Immune Checkpoints and the Immunology of Liver Fibrosis
Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis
Livers (2025) Vol. 5, Iss. 1, pp. 5-5
Open Access | Times Cited: 1
Lactucin alleviates liver fibrosis by regulating the TLR4-MyD88-MAPK/NF-κB signaling pathway through intestinal flora
Liping Zhu, Bo Lv, Yuefeng Gao, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110341-110341
Closed Access | Times Cited: 1
The relationship between telomere length and aging-related diseases
Xiaoqin Huang, Leyi Huang, Jiameng Lu, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Spatial lipidomics reveals sphingolipid metabolism as anti-fibrotic target in the liver
Aleksandra Gruevska, Jack Leslie, Eunkyung An, et al.
Metabolism (2025), pp. 156237-156237
Open Access | Times Cited: 1
Dynamic molecular atlas of cardiac fibrosis at single-cell resolution shows CD248 in cardiac fibroblasts orchestrates interactions with immune cells
Guohua Li, Cheng Ni, Jiacheng Wang, et al.
Nature Cardiovascular Research (2025)
Closed Access | Times Cited: 1
Functional screening and rational design of compounds targeting GPR132 to treat diabetes
Jiale Wang, Xiaodong Dou, Jie Cheng, et al.
Nature Metabolism (2023) Vol. 5, Iss. 10, pp. 1726-1746
Closed Access | Times Cited: 20
Macrophages and platelets in liver fibrosis and hepatocellular carcinoma
Martina Casari, Dominik Siegl, Carsten Deppermann, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease
Yiyuan Zheng, Lina Zhao, Zhekun Xiong, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 3, pp. 449-467
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top